NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/09/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization388.7 mln
Float50.32 mln
Earnings Date08/07/2026
Piotroski F-Score
2
/ 9
Weak
1-Year Forecast
16.28
Transformational upside
Relative Strength
6
/ 100
Severely lagging
Debt / Equity
0.01
Debt-free
ROE
-61.59
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Eupraxia Pharmaceuticals is a Canadian biotechnology company founded in 2011 and based in Victoria, British Columbia. The company has developed its own drug delivery technology, called Diffusphere, which is designed to release medication more effectively in the body. Its lead product is currently in a Phase III clinical trial for knee osteoarthritis, while other treatments targeting conditions of the digestive tract are at earlier stages of development.
